Stocks
Constellation Pharmaceuticals (CNST) EBITDA US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -33.0 | -34.0 | -59.1 | -82.7 | -122.8 | -138.2 | ||
| Changes by years, y/y, % | +3% | +74% | +40% | +49% | +38.9% | ||||
Constellation Pharmaceuticals. EBITDA US GAAP, bln rub
Constellation Pharmaceuticals. EBITDA US GAAP, changes, %
Constellation Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Constellation Pharmaceuticals (CNST) EBITDA US GAAP (quarter values) |
||||||||
| 2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | 2021Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -24.4 | -28.8 | -32.8 | -36.9 | -39.9 | -138.2 | |
| Changes by years, y/y, % | +23% | +39% | +57% | +55% | +63% | |||
| Changes by quarters, q/q, % | +2% | +18% | +14% | +13% | +8% | |||
